Open main menu
Home
Random
Recent changes
Special pages
Community portal
Preferences
About Wikipedia
Disclaimers
Incubator escapee wiki
Search
User menu
Talk
Dark mode
Contributions
Create account
Log in
Editing
Prevalence
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
==Uses== ===Lifetime prevalence=== '''Lifetime prevalence'''<!--Redirects here, bolded per MOS:BOLD--> ('''LTP''') is the proportion of individuals in a population that at some point in their life (up to the time of assessment) have experienced a "case" (e.g., a disease, a traumatic event, or, a behavior, such as committing a crime). Often, a 12-month prevalence (or some other type of "period prevalence") is provided in conjunction with lifetime prevalence. ''Point prevalence'' is the prevalence of disorder at a specific point in time (a month or less). ''Lifetime morbid risk'' is "the proportion of a population that might become afflicted with a given disease at any point in their lifetime."<ref name="Rothman2012">{{cite book|author=Kenneth J. Rothman|title=Epidemiology: An Introduction|url=https://books.google.com/books?id=tKs7adtH-_IC&pg=PA53|date=21 June 2012|publisher=Oxford University Press|isbn=978-0-19-975455-7|page=53}}</ref><ref>{{Cite book| publisher = Oxford University Press| isbn = 978-0-19-937806-7| others = S. Charles Schulz, Michael Foster Green, Katharine J. Nelson (eds.)| title = Schizophrenia and psychotic spectrum disorders|chapter=Chapter 1: Overview of schizophrenia and treatment approaches|last1=Kruse|first1=Matthew|last2=Schulz|first2=S. Charles|page=7|location = New York|date = 2016}}</ref> ===Period prevalence=== '''Period prevalence'''<!--Redirects here, bolded per MOS:BOLD--> is the proportion of the population with a given disease or condition over a specific period of time. It could describe how many people in a population had a cold over the cold season in 2006, for example.{{cn|date=May 2023}} It is expressed as a percentage of the population and can be described by the following formula: Period prevalence (proportion) = Number of cases that existed in a given period Γ· Number of people in the population during this period{{citation needed|date=June 2022}} The relationship between incidence (rate), point prevalence (ratio) and period prevalence (ratio) is easily explained via an analogy with photography. Point prevalence is akin to a flashlit photograph: what is happening at this instant frozen in time. Period prevalence is analogous to a long exposure (seconds, rather than an instant) photograph: the number of events recorded in the photo whilst the camera shutter was open. In a movie each frame records an instant (point prevalence); by looking from frame to frame one notices new events (incident events) and can relate the number of such events to a period (number of frames); see [[Incidence (epidemiology)|incidence rate]].{{citation needed|date=June 2022}} ===Point prevalence=== '''Point prevalence'''<!--Redirects here, bolded per MOS:BOLD--> is a measure of the proportion of people in a population who have a disease or condition at a particular time, such as a particular date. It is like a snapshot of the disease in time. It can be used for statistics on the occurrence of [[chronic diseases]]. This is in contrast to period prevalence which is a measure of the proportion of people in a population who have a disease or condition over a specific period of time, say a season, or a year. Point prevalence can be described by the formula: Prevalence = Number of existing cases on a specific date Γ· Number of people in the population on this date <ref> {{cite book|author=Gerstman, B.B.|year=2003|title=Epidemiology Kept Simple: An Introduction to Traditional and Modern Epidemiology (2nd ed.)|location=Hoboken, NJ|publisher=Wiley-Liss}}</ref>
Edit summary
(Briefly describe your changes)
By publishing changes, you agree to the
Terms of Use
, and you irrevocably agree to release your contribution under the
CC BY-SA 4.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)